Free Trial
LON:PRTC

PureTech Health (PRTC) Share Price, News & Analysis

PureTech Health logo
GBX 142.60 -0.20 (-0.14%)
As of 07/25/2025 12:04 PM Eastern

About PureTech Health Stock (LON:PRTC)

Key Stats

Today's Range
140.40
144.40
50-Day Range
124.40
144.40
52-Week Range
100.40
182.40
Volume
320,561 shs
Average Volume
693,963 shs
Market Capitalization
£428.34 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
GBX 455
Consensus Rating
Buy

Company Overview

Receive PRTC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PureTech Health and its competitors with MarketBeat's FREE daily newsletter.

PRTC Stock News Headlines

Trump’s #1 America First Stock
America’s industrial comeback is underway — and it’s bigger than anyone expected. Over $5 trillion has already been pledged to restore U.S. manufacturing. Trump’s tariffs and trade pressure have set off a massive reshoring push, and the flood of investment is still gaining steam. But while everyone’s watching the big names, one under-the-radar company holds the key tech that could make it all work — and potentially benefit the most.
PureTech Health plc – American Depositary Shares trading resumes
See More Headlines

PRTC Stock Analysis - Frequently Asked Questions

PureTech Health's stock was trading at GBX 150.20 on January 1st, 2025. Since then, PRTC shares have decreased by 5.1% and is now trading at GBX 142.60.

Shares of PRTC stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that PureTech Health investors own include IQE (IQE), Royal Dutch Shell (RDSB), BP (BP), GSK (GSK), Hummingbird Resources (HUM), Plug Power (PLUG) and AstraZeneca (AZN).

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
LON:PRTC
CIK
N/A
Fax
N/A
Employees
300
Year Founded
N/A

Price Target and Rating

High Price Target
GBX 455
Low Price Target
GBX 455
Potential Upside/Downside
+219.1%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

EPS (Trailing Twelve Months)
GBX (24.38)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-£91.86 million
Net Margins
-17,620.94%
Pretax Margin
N/A
Return on Equity
-21.15%
Return on Assets
-13.39%

Debt

Debt-to-Equity Ratio
45.82
Current Ratio
3.68
Quick Ratio
2.51

Sales & Book Value

Annual Sales
£521.32 thousand
Price / Sales
821.65
Cash Flow
GBX 66.58 per share
Price / Cash Flow
2.14
Book Value
GBX 113.55 per share
Price / Book
1.26

Miscellaneous

Outstanding Shares
300,381,095
Free Float
N/A
Market Cap
£428.34 million
Optionable
Not Optionable
Beta
1.02
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (LON:PRTC) was last updated on 7/26/2025 by MarketBeat.com Staff
From Our Partners